Both Eli Lilly LLY and Merck MRK are major players in the U.S. pharmaceutical industry, developing and commercializing ...

Issuing its Q2 earnings review for biopharma, Barclays has picked Eli Lilly (LLY) and Merck (MRK) as its top picks heading into the earnings season. Read more here.

Merck’s stock has declined by close to 10% since early February after the WHO declared the coronavirus a global health emergency, while Eli Lilly stock has fared much better and gained 15%. The ...

Eli Lilly LLY offers a diverse range of products that serve multiple therapeutic areas. While the company’s primary focus is ...

Pharmaceutical heavyweights Merck & Co. Inc. (NYSE: MRK) and Eli Lilly and Company (NYSE: LLY) are getting a lot of attention after outperforming the market by a mile in 2018. Both stocks have ...

Eli Lilly (NYSE: LLY) and Merck (NYSE: MRK) are both among the largest biopharmaceutical businesses in the world, but their growth prospects aren't exactly the same. Nonetheless, the pair handily ...

Sales of Covid-19 drugs fueled year-over-year revenue growth for Merck MRK 0.13 % increase; green up pointing triangle & Co. Inc. and Eli Lilly LLY-2.71 % decrease; red down pointing triangle & Co ...

Few things can jolt a pharmaceutical company's shares like positive results from highly anticipated clinical trials. Even so, ...

Chantal Friebertshäuser, a former executive at Merck and Eli Lilly, will join Moderna as the senior vice president of commercial, Europe, Middle East and Canada, effective Jan. 1.

Pharmaceutical heavyweights Merck & Co. Inc. (NYSE: MRK) and Eli Lilly and Company (NYSE: LLY) are getting a lot of attention after outperforming the market by a mile in 2018. Both stocks have ...

Pharmaceutical heavyweights Merck & Co. Inc. (MRK-0.26%) and Eli Lilly and Company (LLY 3.78%) are getting a lot of attention after outperforming the market by a mile in 2018. Both stocks have ...